All Stories

  1. Exploring T Cell Receptor Repertoires in Myocardial Diseases
  2. The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure—A Prospective Study
  3. Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort
  4. The Association Between Inflammatory Cell Response and Change in Infarct Size Following STEMI
  5. Hallmarks of cardiovascular ageing
  6. Cardioimmunology: the new frontier!
  7. Myocardial Milieu Favors Local Differentiation of Regulatory T Cells
  8. Cardiac relapse of extranodal NK/T-cell lymphoma manifesting as incessant ventricular tachycardia: a case report
  9. HDAC Inhibition Regulates Cardiac Function by Increasing Myofilament Calcium Sensitivity and Decreasing Diastolic Tension
  10. β-Adrenergic Receptor Stimulation Maintains NCX-CaMKII Axis and Prevents Overactivation of IL6R-Signaling in Cardiomyocytes upon Increased Workload
  11. miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium
  12. Rapid differentiation of regulatory CD4+ T cells in the infarcted myocardium blunts in situ inflammation
  13. Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
  14. Ethnic Differences in Serum Levels of microRNAs Potentially Regulating Alcohol Dehydrogenase 1B and Aldehyde Dehydrogenase 2
  15. Mass Spectrometry-Based Redox and Protein Profiling of Failing Human Hearts
  16. Reply to: More data about cardiac and neurologic findings would be useful
  17. Myeloperoxidase-Derived 2-Chlorohexadecanal Is Generated in Mouse Heart during Endotoxemia and Induces Modification of Distinct Cardiomyocyte Protein Subsets In Vitro
  18. CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury
  19. The pulse of fibroblasts: circadian rhythm in pulmonary fibrosis development
  20. Cardiac involvement in a cross‐sectional cohort of myotonic dystrophies and other skeletal myopathies
  21. Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction
  22. Saxagliptin but Not Sitagliptin Inhibits CaMKII and PKC via DPP9 Inhibition in Cardiomyocytes
  23. Reply
  24. A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family
  25. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies
  26. The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients
  27. Desmin Phosphorylation Triggers Preamyloid Oligomers Formation and Myocyte Dysfunction in Acquired Heart Failure
  28. Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study
  29. Unfolding Cardiac Amyloidosis – From Pathophysiology to Cure
  30. Dipeptidyl peptidase-4 independent cardiac dysfunction links saxagliptin to heart failure
  31. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation
  32. Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice
  33. Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium
  34. A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder
  35. Typical STEMI: or not? Embolic left anterior descending artery occlusion, fulminant pulmonary embolism, and in-transit thrombus in a patent foramen ovale
  36. Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G
  37. Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy
  38. Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways
  39. Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine SubpopulationsNovelty and Significance
  40. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
  41. Response to Letter from Villa-Abrille et al
  42. Precardiac deletion of Numb and Numblike reveals renewal of cardiac progenitors
  43. Cardiomyocyte-Specific Transforming Growth Factor   Suppression Blocks Neutrophil Infiltration, Augments Multiple Cytoprotective Cascades, and Reduces Early Mortality After Myocardial Infarction
  44. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy
  45. Hyperactive Adverse Mechanical Stress Responses in Dystrophic Heart Are Coupled to Transient Receptor Potential Canonical 6 and Blocked by cGMP-Protein Kinase G Modulation
  46. HNO Enhances SERCA2a Activity and Cardiomyocyte Function by Promoting Redox-Dependent Phospholamban Oligomerization
  47. Bile acids induce arrhythmias in human atrial myocardium—implications for altered serum bile acid composition in patients with atrial fibrillation
  48. A Swinging Pacemaker Lead Promoting Endocarditis and Severe Tricuspid Regurgitation
  49. Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes
  50. Cardiac Fibrosis in Human Transplanted Hearts Is Mainly Driven by Cells of Intracardiac Origin
  51. Dependence of β3-adrenergic signaling on the adipokine leptin in cardiac myocytes
  52. Glucose-transporter–mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients
  53. Esophageal ulceration mimicking malignancy in a patient with severe kyphoscoliosis
  54. Functional effects of glucose transporters in human ventricular myocardium